drugset / Trial / NCT00274430

Prevention of High Altitude Pulmonary Edema

NCT00274430

Phase 1/2 Completed 30 enrolled University of Zurich
RandomizedParallel-groupDouble-blindPrevention

Summary

A double-blind placebo controlled study * To compare the effect of tadalafil and dexamethasone versus placebo on Ppa and pulmonary edema formation in subjects susceptible to HAPE. * To investigate the effect of dexamethasone on alveolar fluid clearance, as assessed by measurement of the nasal potential difference, and prevention of HAPE. * To investigate the effect of the tadalafil and dexamethasone versus placebo on the dynamic CBF autoregulation properties and on the development of AMS in HAPE susceptible subjects.

Timeline

Start
2003-07
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg
Subject Tadalafil Small molecule 10 mg